Nano-X Imaging (NNOX) Asset Writedowns and Impairment (2021 - 2024)
Nano-X Imaging (NNOX) posted quarterly Asset Writedowns and Impairment of $86000.0 for Q4 2024, down 98.78% year-on-year from $7.1 million in Q1 2024, and up 256.36% on a QoQ basis from -$55000.0 in Q3 2024.
Nano-X Imaging (NNOX) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends
Nano-X Imaging (NNOX) has reported Asset Writedowns and Impairment for 4 consecutive years, with $86000.0 the latest figure, recorded in Q4 2024.
- Quarterly Asset Writedowns and Impairment fell 98.78% year-over-year to $86000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $202000.0 (down 97.46% YoY) and the FY2025 annual result came in at $17.5 million, up 8577.23% from the prior year.
- Asset Writedowns and Impairment improved to $86000.0 in Q4 2024 per NNOX's latest filing, from -$55000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for NNOX reached as high as $36.5 million in Q4 2022 and fell as low as -$55000.0 in Q3 2024.
- A 4-year average of $5.4 million and a median of $145000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment surged 91250.0% — and 2024, when it slumped 107.45%.
- Year by year, Asset Writedowns and Impairment stood at $40000.0 in 2021, then jumped by 91250.0% to $36.5 million in 2022, then sank by 80.69% to $7.1 million in 2023, then plunged by 98.78% to $86000.0 in 2024.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $86000.0, -$55000.0, and $146000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Nano-X Imaging | 62,810.26 | -44.16 Mn | -2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 86,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | -55,000.00 |
| Sep 30, 2024 | -55,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Jun 30, 2024 | 146,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 7.06 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 738,000.00 |
| Sep 30, 2023 | 738,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Mar 31, 2023 | 145,000.00 |
| Dec 31, 2022 | 36.54 Mn |
| Dec 31, 2022 | 36.54 Mn |
| Jun 30, 2022 | 14.34 Mn |
| Jun 30, 2022 | 14.34 Mn |
| Mar 31, 2022 | 28,000.00 |
| Mar 31, 2022 | 28,000.00 |